Gamco Investors INC. ET AL lifted its holdings in Danaher Co. (NYSE:DHR) by 2.5% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 9,580 shares of the conglomerate’s stock after purchasing an additional 233 shares during the period. Gamco Investors INC. ET AL’s holdings in Danaher were worth $1,384,000 as of its most recent filing with the SEC.
Several other institutional investors have also bought and sold shares of DHR. Dorsey Wright & Associates increased its stake in shares of Danaher by 1.5% in the second quarter. Dorsey Wright & Associates now owns 32,512 shares of the conglomerate’s stock worth $4,647,000 after purchasing an additional 467 shares during the period. WINTON GROUP Ltd increased its stake in shares of Danaher by 255.9% in the second quarter. WINTON GROUP Ltd now owns 16,441 shares of the conglomerate’s stock worth $2,350,000 after purchasing an additional 11,821 shares during the period. KAMES CAPITAL plc bought a new position in shares of Danaher in the second quarter worth about $2,868,000. Empirical Finance LLC bought a new position in shares of Danaher in the second quarter worth about $212,000. Finally, Calton & Associates Inc. bought a new position in shares of Danaher in the second quarter worth about $458,000. Institutional investors and hedge funds own 78.30% of the company’s stock.
DHR stock traded up $0.73 during trading on Friday, reaching $135.23. 1,633,369 shares of the stock were exchanged, compared to its average volume of 2,487,994. Danaher Co. has a twelve month low of $94.59 and a twelve month high of $147.33. The company has a market capitalization of $95.87 billion, a P/E ratio of 29.92, a price-to-earnings-growth ratio of 2.24 and a beta of 0.92. The stock has a 50 day simple moving average of $139.07 and a 200-day simple moving average of $138.28. The company has a current ratio of 3.43, a quick ratio of 3.09 and a debt-to-equity ratio of 0.52.
Danaher (NYSE:DHR) last released its earnings results on Thursday, October 24th. The conglomerate reported $1.16 earnings per share for the quarter, topping analysts’ consensus estimates of $1.15 by $0.01. The business had revenue of $5.04 billion for the quarter, compared to the consensus estimate of $5.02 billion. Danaher had a return on equity of 11.42% and a net margin of 12.13%. The firm’s revenue for the quarter was up 3.8% compared to the same quarter last year. During the same period last year, the business earned $1.10 earnings per share. Equities analysts predict that Danaher Co. will post 4.76 EPS for the current year.
The business also recently disclosed a quarterly dividend, which was paid on Friday, October 25th. Shareholders of record on Friday, September 27th were issued a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a yield of 0.50%. The ex-dividend date was Thursday, September 26th. Danaher’s payout ratio is 15.04%.
A number of equities analysts have recently commented on DHR shares. ValuEngine lowered Danaher from a “buy” rating to a “hold” rating in a research note on Wednesday, October 2nd. Piper Jaffray Companies lifted their target price on Danaher from $148.00 to $153.00 and gave the stock a “neutral” rating in a research report on Thursday, July 18th. Credit Suisse Group reissued an “outperform” rating and set a $151.00 target price on shares of Danaher in a research report on Monday, October 14th. Needham & Company LLC decreased their target price on Danaher from $155.00 to $152.00 and set a “buy” rating on the stock in a research report on Monday, October 28th. Finally, Royal Bank of Canada set a $134.00 target price on Danaher and gave the stock a “hold” rating in a research report on Friday, July 19th. Four equities research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus target price of $145.86.
In related news, Chairman Mitchell P. Rales acquired 2,500 shares of the firm’s stock in a transaction on Friday, August 23rd. The shares were bought at an average cost of $139.52 per share, with a total value of $348,800.00. Following the completion of the acquisition, the chairman now owns 3,030,453 shares of the company’s stock, valued at $422,808,802.56. The acquisition was disclosed in a filing with the SEC, which is accessible through the SEC website. 11.40% of the stock is currently owned by insiders.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.
Recommended Story: The benefits and drawbacks of dollar cost averaging
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.